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Cholestasis represents one of the main 
causes of hepatotoxicity. It is defined by im-
paired bile flux from hepatocytes to the gall 
bladder. Cholestasis can be caused by inhibi-
tion of the transport of bile acids from 
hepatocytes into bile canaliculi. Moreover, 
physical obstructions or impaired flux in the 
canaliculi or bile ducts may be responsible. 
Since decades cultivated hepatocytes have 
been used to study the cholestatic properties 
of chemicals (Dunn et al., 1989). Tests in 
this field are based on the release and subse-
quent analysis of the canalicular content (Liu 
et al., 1999a-c; Bi et al., 2006; Kostrubsky et 
al., 2003). However, relatively little is 
known whether compromised bile canalicu-
lar dynamics, the rhythmic contractions of 
bile canaliculi, play a role in cholestasis. 
Therefore, Raymond Reif and colleagues 
have established an in vitro system that 
based on time-lapse microscopy allows the 
quantification of bile canalicular dynamics 
(Reif et al., 2015). This technique measures 
the repetitive swelling and collapsing of bile 
canaliculi. This period typically lasts for ap-
proximately 30 h after plating of mouse 
hepatocytes. Afterwards, the luminal diame-
ter of the bile canaliculi becomes narrower 
and more constant (Reif et al., 2015). In this 
state it resembles morphology and dynamics 
of bile canalicular structures in vivo (Reif et 
al., 2015). An interesting observation is that 
exposure to dexamethasone/insulin increased 
both, the amplitude of the initial contractions 
during the first 30 h and also the diameter of 
the mature canaliculi between 30 and 75 h 
after plating of the hepatocytes. In conclu-
sion, Reif and colleagues have established a 
relatively easy to handle technique to quanti-
fy bile canalicular dynamics and they have 
shown that this parameter can be influenced 
by chemicals. However, whether compro-
mised bile canalicular dynamics play a key 
role in pathogenesis of cholestasis still re-
mains to be studied in future.  
Prediction of hepatotoxicity represents a 
cutting edge topic in toxicology (Ghallab et 
al., 2015; Godoy et al., 2009, 2013, 2015; 
Kim et al., 2015; Hengstler et al., 2014; 
Drasdo et al., 2014a, b; Frey et al., 2014; 
Mazzanti et al., 2015; Tolosa et al., 2015; 
Chen et al., 2014; Vitins et al., 2014; Liu et 
al., 2014). An intensively studied field are in 
vitro systems for hepatotoxicity, because 
they may improve the throughput and avoid 
difficulties due to interspecies extrapolation, 
because human cells can be used (Schyschka 
et al., 2013; Messner et al., 2013; Wobus and 
Löser, 2011; O’Brien et al., 2006). However, 
because of their limitations, in vitro systems 
have also been critically discussed (Reif, 
2014; Ghallab, 2013, 2014a, b; Stöber, 2014; 
Hammad, 2013). Many in vitro systems in 
the field of hepatotoxicity focus on altera-
tions in gene expression caused by the test 
compounds (Shinde et al., 2015a, b; Campos 
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et al., 2014; Rodrigues et al., 2013; Driessen 
et al., 2013; Tolosa et al., 2013; Grinberg et 
al., 2014). Other endpoints, such as bile can-
alicular dynamics have been studied only 
rarely, possibly due to technical challenges. 
Therefore, it is fortunate that techniques for 
analysis of bile canalicular dynamics are 
now available. However, if - and if yes to 
which degree - compromised motility of bile 
canaliculi contributes to hepatotoxicity still 
has to be elucidated.  
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